NCT00000678View on ClinicalTrials.gov

Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.

PHASE2CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

Not specified

Primary Completion Date

July 31, 1992

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

DRUG

Zalcitabine

Trial Locations (10)

12203

Albany Med College / AIDS Treatment Ctr, Albany

19146

Graduate Hosp, Philadelphia

21287

Johns Hopkins Hosp, Baltimore

70112

Tulane Univ School of Medicine, New Orleans

75219

N Texas Ctr for AIDS & Clin Rsch, Dallas

94114

Davies Med Ctr, San Francisco

94115

Mount Zion Med Ctr, San Francisco

331361013

Univ of Miami School of Medicine, Miami

452670405

Holmes Hosp / Univ of Cincinnati Med Ctr, Cincinnati

462025250

Indiana Univ Hosp, Indianapolis

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000678 - Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy. | Biotech Hunter | Biotech Hunter